Chapter 42 - The Ouroboros Syndicate
The realization that they were under a highly sophisticated, global attack forced the foundation’s command center into immediate high alert. The sunlit tranquility of the afternoon was instantly replaced by the frantic, electric hum of servers and ringing secure lines. Olivia stood at the head of the massive glass conference table, surrounded by her elite legal and cybersecurity teams, demanding answers.
"I want to know exactly who drafted this emergency medical privacy injunction," Olivia commanded, her voice cutting through the chaotic chatter of the room like a perfectly sharpened blade. "You do not rewrite international healthcare regulations overnight without leaving a massive, traceable financial footprint. Find the money."
Marcus, her chief digital forensic investigator, rapidly typed across his multi-monitor setup. "The injunction was sponsored by a coalition of five private healthcare think tanks. But they are just shell entities, Olivia. I’m tracing their funding origins through offshore holding accounts right now. It’s a labyrinth of dark money, bouncing through the Cayman Islands, Switzerland, and Luxembourg."
"Keep digging," Arthur urged, standing closely by Olivia’s side, his eyes scanning the cascading streams of data. "Billionaires always leave a breadcrumb trail. They can't help themselves; their arrogance eventually outweighs their caution."
For three agonizing hours, the team worked in absolute silence, peeling back the heavy layers of corporate obfuscation. Finally, a single, recurring digital signature emerged from the encrypted ledgers.
"I have a match," Marcus announced, his voice dropping to a cautious whisper as a new logo populated the primary presentation screen. It was an image of a serpent eating its own tail, rendered in stark, minimalist black.
"Ouroboros Pharmaceuticals," Olivia read aloud, a cold, terrifying recognition washing over her.
Ouroboros wasn't just a company; it was a sprawling, multi-trillion-dollar pharmaceutical empire that held an absolute monopoly on traditional chemotherapy drugs and extended oncology treatments. They didn't cure cancer; they managed it, profiting astronomically from prolonged, agonizing patient treatments. David’s AI, which caught the disease early enough to render their most expensive chemical treatments completely obsolete, was an existential threat to their entire business model.
May you like
"The CEO is a man named Elias Blackwood," Arthur said, pulling up a dossier of a sharp-featured, ruthlessly handsome man with dead, calculating eyes. "He makes Victoria Harrington look like an amateur. Harrington wanted power and status. Blackwood wants total global control over human mortality."
Olivia stared at the photograph of the man who had just declared war on her son’s legacy. She didn't feel the suffocating panic she used to experience. She felt a deep, uncompromising rage. "Prepare the legal teams," Olivia commanded softly. "We are going to tear Ouroboros apart."
